Arcturus Therapeutics
ARCT
$26.63
Share price
0.30%
Change (1 day)
1.95%
Change (1 year)
Arcturus Therapeutics (ARCT) - Total assets
Total assets on the balance sheet as of December 2023 : $0.42 B
According to Arcturus Therapeutics 's latest financial reports the company's total assets are $0.42 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Arcturus Therapeutics - Total assets on balance sheet (from 2012 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.42 B | -4.66% |
| 2022-12-31 | $0.45 B | 14.66% |
| 2021-12-31 | $0.39 B | -17.56% |
| 2020-12-31 | $0.47 B | 480.03% |
| 2019-12-31 | $82.14 M | 85.85% |
| 2018-12-31 | $44.19 M | -15.04% |
| 2017-12-31 | $52.02 M | 278.74% |
| 2016-12-31 | $13.73 M | -80.84% |
| 2015-12-31 | $71.68 M | 221.19% |
| 2014-12-31 | $22.31 M | -55.65% |
| 2013-12-31 | $50.32 M | 24936.82% |
| 2012-12-31 | $0.2 M | -83.31% |
| 2011-12-31 | $1.2 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $0.27 M | -99.94% | Bahamas |
 NRC Health
NRC | $0.12 B | -71.49% | 🇺🇸 USA |